Invasive aspergillus tracheobronchitis (AT) in non-neutropenic, immunocompromised patients

R. Krenke, E. M. Grabczak, A. Kolkowska-Lesniak, M. Przybylski, M. Prochorec-Sobieszek, L. Konopka, R. Chazan (Warsaw, Poland)

Source: Annual Congress 2008 - Rare clinical cases
Session: Rare clinical cases
Session type: Thematic Poster Session
Number: 563
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Krenke, E. M. Grabczak, A. Kolkowska-Lesniak, M. Przybylski, M. Prochorec-Sobieszek, L. Konopka, R. Chazan (Warsaw, Poland). Invasive aspergillus tracheobronchitis (AT) in non-neutropenic, immunocompromised patients. Eur Respir J 2008; 32: Suppl. 52, 563

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Invasive pulmonary aspergillosis in immunosuppressed patients
Source: International Congress 2015 – How to approach and treat fungal and viral respiratory infections
Year: 2015



Our patients of candida and aspergillus pneumonia
Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections
Year: 2009

The diagnostic approach to pulmonary infiltrates in the neutropenic and non-neutropenic immunocompromised host
Source: Annual Congress 2010 - Managing pulmonary complications in the immunocompomised host
Year: 2010


Pulmonary infections in neutropenic patients
Source: Eur Respir J 2003; 22: Suppl. 45, 334s
Year: 2003

Nocardia community-acquired pneumonia in immunocompetent and immunocompromised host
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009


Breakthrough invasive pulmonary aspergillosis (IPA) in patients receiving posaconazole prophylaxis (PPxis)
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014


Clinical and radiological features of pneumocystis pneumonia in immunocompromised non-HIV patients
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016


Virological diagnosis in community-acquired pneumonia in immunocompromised patients
Source: Eur Respir J 2008; 31: 618-624
Year: 2008



Pneumonia in the immunocompromised patient
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=200
Year: 2006

Treatment outcome in patients with chronic pulmonary aspergillosis by azole-resistant aspergillus fumigatus
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016


Fungal lung infections in critically-ill patients
Source: International Congress 2016 – PG19 The lung in the septic critically-ill patient
Year: 2016



Prognosis of pneumocystis jirovecii pneumonia in non-HIV patients
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013

Outbreak of pneumocystis jiroveci pneumonia among renal transplant patients
Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment
Year: 2013


Detection parachlamydia acanthamoeba and simkania negevensis in young patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2004; 24: Suppl. 48, 412s
Year: 2004

Invasive pulmonary aspergillosis in patients with severe COPD. Compative study between probable invasive infection and colonization
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011


Treatment of chronic necrotizing pulmonary aspergillosis (CNPA) with micafungin (MCFG)
Source: Eur Respir J 2005; 26: Suppl. 49, 410s
Year: 2005

Invasive fungal infections in acute leukemia patients.
Source: Virtual Congress 2021 – Fungi, viruses, parasites and the immunocompromised
Year: 2021